Physician profile
Christopher T Grubb
NPI 1699741421
$3,997.53
in general payments reported to CMS, 2019-2025
26 companies · $765 in 2025
The $765 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $43.41 · 2021: $354 · 2022: $798 · 2023: $873 · 2024: $788 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,400 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,399.61 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $844.17 | 2022-2025 | Eterna, Proclaim |
| Medtronic, INC. | $690.80 | 2021-2023 | Intellis Adaptivestim |
| Boston Scientific Corporation | $430.94 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept, Artisan |
| Saluda Medical Americas, INC. | $341.31 | 2023 | Evoke Scs |
| Medtronic USA, INC. | $237.87 | 2019-2020 | |
| Abbvie INC. | $235.15 | 2021-2025 | |
| Spinal Simplicity, LLC | $135.83 | 2025 | Ha Minuteman G3-R |
| Spr Therapeutics, INC | $132.73 | 2024-2025 | Sprint Pns System |
| Avanos Medical | $131.74 | 2020-2022 | |
| Painteq LLC | $114.38 | 2023 | Painteq |
| Pfizer INC. | $113.36 | 2019 | |
| Merck Sharp & Dohme LLC | $112.57 | 2020-2025 | Bridion |
| Vertex Pharmaceuticals Incorporated | $77.13 | 2025 | |
| Masimo Corporation | $77.06 | 2022-2024 | Sedline, Set and Rainbow Set |
| Cumberland Pharmaceuticals, INC. | $59.07 | 2021-2023 | Caldolor |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $53.44 | 2021 | |
| Arbor Pharmaceuticals, INC. | $29.50 | 2021 | |
| Electronic Waveform Lab, INC. | $26.93 | 2019 | |
| Fisher & Paykel Healthcare INC | $24.68 | 2025 | Fisher & Paykel Healthcare |
| Forte Bio-Pharma LLC | $23.87 | 2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $23.14 | 2023 | Belbuca |
| Biohaven Pharmaceuticals, INC. | $21.15 | 2021 | |
| Teleflex LLC | $17.23 | 2022 | |
| Trevena, INC. | $16.11 | 2022 | |
| Acacia Pharma INC | $14.32 | 2022 | |
| Mallinckrodt Enterprises LLC | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Grubb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.